Humoral Immunology Core Laboratory for AIDS Vaccine Research
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N93023R00012
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, National Institute of Allergy and Infectious Diseases seeks proposals to establish a nonhuman primate core humoral immunology laboratory to support AIDS vaccine research and development. The contractor will conduct assays to evaluate and characterize the humoral immune responses of nonhuman primates immunized with candidate HIV or SIV vaccines or infected with related viruses. Proposals are due February 16, 2024 and will be evaluated based on technical approach, qualifications, and cost/price. The base period of performance is January 31, 2025 through January 30, 2026, with options to extend up to five additional years.
There is no set-aside designation. The NAICS code is 541715 and PSC code is R425. The contractor must conduct approximately 500 ADCC assays and 200 ADCP assays annually, produce viral stocks, and perform binding and epitope mapping assays to support NIH Simian Vaccine Evaluation Units and collaborating investigators. The place of performance is within the United States. Amendments to the RFP provided additional clarification on technical assumptions and responded to questions from potential offerors.
Notice text
3 versions
Update #3 · Latest ·
Amendment No. 2: RFP No.: 75N93023R00012: The purpose of this Amendment is to provide responses to questions from potential offerors, regarding the solicitation. Amendment No. 2 is attached below.
Amendment No. 1: RFP No.: 75N93023R00012: The purpose of this Amendment is to provide a response to a question from a potential offeror, regarding the solicitation. Amendment No. 1 is attached below.
Please see the attached PDF for the solicitation notice (75N93023R00012).
Update #2 ·
Amendment No. 1: RFP No.: 75N93023R00012: The purpose of this Amendment is to provide a response to a question from a potential offeror, regarding the solicitation. Amendment No. 1 is attached below.
Please see the attached PDF for the solicitation notice (75N93023R00012).
Update #1 ·
Please see the attached PDF for the solicitation notice (75N93023R00012).
Files
| File | Type | Posted |
|---|---|---|
| Amendment 2 RFP 75N93023R00012.pdf | ||
| Amendment 1 RFP 75N93023R00012.pdf | ||
| 75N93023R00012 with Attachments.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Humoral Immunology Core Laboratory for AIDS Vaccine Research | Award Notice | |
| This notice | Solicitation | |
| Humoral Immunology Core Laboratory for AIDS Vaccine Research | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity